BRPI0821895A2 - PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS - Google Patents

PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS

Info

Publication number
BRPI0821895A2
BRPI0821895A2 BRPI0821895-1A2A BRPI0821895A BRPI0821895A2 BR PI0821895 A2 BRPI0821895 A2 BR PI0821895A2 BR PI0821895 A BRPI0821895 A BR PI0821895A BR PI0821895 A2 BRPI0821895 A2 BR PI0821895A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
symptoms
disease
prevention
preparation
Prior art date
Application number
BRPI0821895-1A2A
Other languages
Portuguese (pt)
Inventor
Robert Shorr
Robert Rodriguez
Original Assignee
Robert Shorr
Robert Rodriguez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Shorr, Robert Rodriguez filed Critical Robert Shorr
Publication of BRPI0821895A2 publication Critical patent/BRPI0821895A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0821895-1A2A 2008-04-04 2008-04-04 PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS BRPI0821895A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/004393 WO2009123595A1 (en) 2008-04-04 2008-04-04 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents

Publications (1)

Publication Number Publication Date
BRPI0821895A2 true BRPI0821895A2 (en) 2014-10-07

Family

ID=41135838

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821895-1A2A BRPI0821895A2 (en) 2008-04-04 2008-04-04 PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS

Country Status (9)

Country Link
EP (1) EP2262369A4 (en)
JP (1) JP2011516472A (en)
KR (1) KR20110009128A (en)
CN (1) CN102046011A (en)
AU (1) AU2008354007A1 (en)
BR (1) BRPI0821895A2 (en)
CA (1) CA2720390A1 (en)
IL (1) IL208386A0 (en)
WO (1) WO2009123595A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110056042A (en) * 2009-11-20 2011-05-26 주식회사유한양행 Nano particles for tumor-targeting and processes for the preparation thereof
CL2012001399A1 (en) 2009-12-03 2013-03-08 Novartis Ag Method to manufacture adjuvant for vaccine (oil / water emulsion with squalene, polysorbate 80 and sorbitan trioleate), which comprises (i) forming the first emulsion in a homogenizer from one container to another to form a second emulsion, (ii) and microfluidizing the first emulsion to form second emulsion.
EP2356983B1 (en) 2009-12-03 2013-02-20 Novartis AG Circulation of components during homogenization of emulsions
DE102009056871A1 (en) * 2009-12-03 2011-06-22 Novartis AG, 4056 Vaccine adjuvants and improved methods of making the same
NZ599881A (en) * 2009-12-03 2014-01-31 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
MX341082B (en) 2010-05-03 2016-08-08 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same.
WO2013112249A1 (en) 2012-01-24 2013-08-01 University Of Southern California Digital circuit power measurements using numerical analysis
JO3685B1 (en) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc Non-aqueous taxane nanodispersion formulations and methods of using the same
US10220095B2 (en) 2013-03-15 2019-03-05 Taiwan Liposome Company, Ltd Controlled drug release liposome compositions and methods thereof
US9693958B2 (en) 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
US11172675B2 (en) * 2014-12-22 2021-11-16 Oro Agri Inc. Nano particulate delivery system
US10386395B1 (en) 2015-06-03 2019-08-20 University Of Southern California Subcircuit physical level power monitoring technology for real-time hardware systems and simulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401396A4 (en) * 2001-06-15 2009-08-05 Cornerstone Pharmaceuticals Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
ES2283756T3 (en) * 2002-03-01 2007-11-01 Novagali Pharma Sa PHARMACO ADMINISTRATION ADMINISTRATION SYSTEMS FOR TAXOIDS.
CN1671727A (en) * 2002-07-25 2005-09-21 麦克洛基克斯生物技术有限公司 Anti-viral 7-deaza D-nucleosides and uses thereof
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20060257493A1 (en) * 2005-04-28 2006-11-16 Amiji Mansoor M Nanoparticulate delivery systems for treating multi-drug resistance
US20070148194A1 (en) * 2005-11-29 2007-06-28 Amiji Mansoor M Novel nanoemulsion formulations

Also Published As

Publication number Publication date
CA2720390A1 (en) 2009-10-08
AU2008354007A1 (en) 2009-10-08
JP2011516472A (en) 2011-05-26
KR20110009128A (en) 2011-01-27
IL208386A0 (en) 2010-12-30
WO2009123595A1 (en) 2009-10-08
EP2262369A1 (en) 2010-12-22
EP2262369A4 (en) 2013-05-29
CN102046011A (en) 2011-05-04

Similar Documents

Publication Publication Date Title
BRPI0821895A2 (en) PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS
BRPI1009860A2 (en) compound, use thereof, pharmaceutical composition and method for the therapeutic treatment or prevention of disease in humans or animals
BRPI0822162A8 (en) method for treating nail or nail bed disease and pharmaceutical composition for topical treatment of nail or nail bed disease.
BRPI0811436A2 (en) COMPOUND, USE OF A COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR PAIN THERAPY IN A HOT BLOOD ANIMAL, SUPER ACTIVE BLADDER THERAPY IN A HOT BLOOD ANIMAL, AND TO PREPARE A COMPOUND.
BRPI0911520A2 (en) new therapeutic approaches for the treatment of alzheimer&#39;s disease and related diseases through angiogenesis modulation.
BR112013010665A2 (en) system for treating a medical condition in humans or animals, method of treating a medical condition in humans or animals with one or more therapeutic agents, device for treating a medical condition in humans or animals, and catheter device for administering a fluid to a blood vessel
BRPI0717697A2 (en) compound, pharmaceutical composition, use of the compound, method of treating a patient suffering from a pathological condition or disease and combination of products
BRPI0819916A2 (en) Antigen binding protein, pharmaceutical composition, method for treating a human patient afflicted with a disease, antibody or fragment thereof, and antigen binding protein.
BRPI0810081A2 (en) THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR BRAIN DISEASES
DE602006014691D1 (en) DIAGNOSIS, TREATMENT AND PREVENTION OF VASCULAR DISEASES USING IL-1alpha AUTOANTIC BODIES
BRPI0922817A2 (en) absorbent medical staff, in particular for removing wound fluids from human and / or animal body cavities and methods for their production
WO2012087742A3 (en) Methods and compositions suitable for managing blood glucose in animals
BRPI0812384A2 (en) TREATMENT, DIAGNOSTIC AND DISEASE TREATMENT METHODS ASSOCIATED WITH FGF21
BRPI0909557A2 (en) bandage set, reduced pressure treatment system, and system to assist in healing a wound in a patient.
BRPI0814957A2 (en) COMPOUND, PRODUCT, PHARMACEUTICAL AGENT, METHOD FOR PROPHYLAXY OR TREATMENT OF A DISEASE, DISORDER OR CONDITION, AND USE OF THE COMPOUND.
BRPI1012066A2 (en) oral care composition, and methods for preparing the oral care composition and for administering a zinc compound to an animal or human individual in need thereof
WO2008149802A1 (en) Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient
BRPI0814339A2 (en) pharmaceutical composition, kit for the preparation of the pharmaceutical composition, conjugate and methods for in vivo optical imaging of the mammalian body, and for the detection, stabilization, diagnosis, monitoring of disease progress or monitoring of the treatment of a disease state. mammal body
BRPI1012051A2 (en) &#34;oral care composition, polymeric matrix film, and methods for preparing the film, and for treating an oral cavity disease or condition&#34;
BRPI0813882A2 (en) COMPOSITIONS AND TREATMENT OF HEART FAILURE IN NONHUMAN MAMMAL ANIMALS.
BRPI0918398A2 (en) Method for diagnosing a physiological abnormality in a patient, System for diagnosing a physiological abnormality in a patient, Catheter and Device for diagnosing a physiological abnormality in a patient
BRPI0818841A2 (en) Compounds for use in imaging, diagnosis and / or treatment of central nervous system or tumor disease
BRPI0913854A2 (en) compound, pharmaceutical composition, use of the compound, and, method for treating, preventing or alleviating a disease or disorder or condition of a living animal organism.
BR112015006656A8 (en) compositions and methods for the treatment of heart failure in diabetic patients
BRPI0612624A2 (en) methods for treating vascular disease in a human, and for preventing and / or treating a thrombosis-induced disease or a thromboembolism-induced disease in a human, and use of a compound

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8,6 NA RPI 2343 DE 01/12/2015

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2432 DE 15/08/2017.